NEXI
$12.88
Neximmune
NEXI
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.67)
Revenue:  $0.00 Mil
Monday
Nov 8
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NEXI reports earnings?
Beat
Meet
Miss

Where is NEXI's stock price going from here?
Up
Flat
Down
Stock chart of NEXI
Analysts
Summary of analysts' recommendations for NEXI
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
NexImmune Inc. is a clinical-stage biotechnology company. It engages in developing a novel approach to immunotherapy designed to employ the body's own T cells to generate a specific, potent and durable immune response that mimics natural biology. NexImmune Inc. is based in GAITHERSBURG, Md.